(153 days)
Not Found
No
The device description and performance studies focus on basic heat therapy using an infrared bulb and do not mention any AI or ML components or functionalities.
Yes
The device description explicitly states, "The Infrared Heating Device, Model PM-750, is ... a therapeutic medical device." Additionally, its intended use is to "temporarily relieve minor muscle and joint aches and pains," which is a therapeutic function.
No
The device is described as a "therapeutic medical device that provides continuous heat therapy" for temporary relief of muscle and joint aches and pains and increased local blood circulation. Its function is to provide therapy, not to diagnose a condition.
No
The device description explicitly states it is a hardware device consisting of a handle, electronics, controls, an infrared bulb, and a light filter. It is powered by 110V AC and provides heat therapy through the infrared bulb.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to temporarily increase local blood circulation and relieve minor muscle and joint aches and pains. This is a therapeutic purpose, not a diagnostic one.
- Device Description: The device provides continuous heat therapy through an infrared bulb applied to the skin. This is a physical therapy modality, not a test performed on biological samples outside the body.
- No mention of biological samples: IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening. There is no indication that this device interacts with or analyzes any biological samples.
Therefore, the Infrared Heating Device, Model PM-750, is a therapeutic medical device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Infrared Heating Device, Model PM-750, temporarily increases local blood circulation where applied, and temporarily relieves minor muscle and joint aches and pains.
Product codes (comma separated list FDA assigned to the subject device)
ILY
Device Description
The Infrared Heating Device, Model PM-750, is 110V AC powered, non-invasive, therapeutic medical device that provides continuous heat therapy through the use of infrared bulb. The device consists of a handle that houses the electronics and controls, and tungsten infrared bulb with light filter. The light filter is intended to be placed directly on the skin to provide topical heating. The infrared bulb is replaceable. The housing material is ABS.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing of Infrared Heating Device, Model PM-750, includes electrical safety testing and performance testing.
In addition, two devices were tested for heat output, with the infrared light filter contacting the skin. Temperatures were recorded every 1 minute, up to 30 minutes, using a digital temperature sensor, through 6 participants on different body part. The test results concluded that the Infrared Heating Device, Model PM-750 was able to maintain temperature above 40℃ (the desired effective temperature) at least 10~15 minutes of the 30 minutes cycle time. The tests also showed that the temperature at the sensor (skin) never exceeded a temperature of 45℃. Both devices used for this test tracked each near 100%.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 890.5500 Infrared lamp.
(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.
0
Image /page/0/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern. Inside the circle is a stylized image of three human profiles facing right, with flowing lines representing hair or clothing.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 3, 2014
Pro Medical Supplies Inc. c/o Ms. Doris Dong Shanghai CV Technology Co., Ltd. Room 1706, No. 128 Songle Rd., Songjiang Area, Shanghai. China 201600
Re: K140865
Trade Name: Infrared Heating Device, Model PM-750 Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared Lamp Regulatory Class: Class II Product Code: ILY Dated: July 17, 2014 Received: July 28, 2014
Dear Ms. Dong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
1
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Felipe Aguel -S
Carlos L. Peña, PhD, MS for Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K140865
Device Name Infrared Heating Device, Model PM-750
Indications for Use (Describe)
The Infrared Heating Device, Model PM-750, temporarily increases local blood circulation where applied, and temporarily relieves minor muscle and joint aches and pains.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
× Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
)14 (19 2 -04 00
3
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Section 5 510(k) Summary [As required by 21 CFR 807.92]
1. Submission Information:
| 510(k) Number: | K140865 |
|---|---|
| Date: | July 15th, 2014 |
| Type of 510(k) Submission: | Traditional |
| Basis for 510(k) Submission: | New device |
| Applicant/US importer: | Pro Medical Supplies Inc. |
| 1800 Byberry Rd. Unit 905, Huntingdon Valley, PA 19006, USA | |
| Manufacturer: | Shenzhen Yizekang Technologies Co., Ltd. |
| 2nd Floor, No. 6 Factory, Hekan Road, Hekan Village, | |
| Bantian Sub-District, Longgang District, Shenzhen 518131, China | |
| Contactor: | Doris Dong (Consultant) |
| Shanghai CV Technology Co., Ltd. | |
| Room 1706, No. 128 Songle Rd., Songjiang Area, Shanghai, China 201600 | |
| E-mail: doris_d@126.com | |
| 2. Device Description: | |
| Proprietary Name: | Infrared Heating Device, Model PM-750 |
| Common Name: | Infrared lamp |
| Classification Name: | Infrared lamp |
| Product Code: | ILY |
| Device Class: | 2 |
| Review Panel: | Physical Medicine |
| Regulation Number: | 890.5500 |
| Indications for use: | The Infrared Heating Device, Model PM-750, temporarily increases local |
| blood circulation where applied, and temporarily relieves minor muscle | |
| and joint aches and pains. | |
| Device Description: | The Infrared Heating Device, Model PM-750, is 110V AC powered, |
| non-invasive, therapeutic medical device that provides continuous heat | |
| therapy through the use of infrared bulb. The device consists of a handle | |
| that houses the electronics and controls, and tungsten infrared bulb with | |
| light filter. The light filter is intended to be placed directly on the skin to | |
| provide topical heating. The infrared bulb is replaceable. The housing | |
| material is ABS. | |
| Standards: | AAMI ANSI ES60601-1, IEC 60601-1-2, ISO 10993-1, ISO 10993-5, ISO |
| 10993-10 | |
3. Predicate Device Identification
| 510k Number: | K990233 |
|---|---|
| Product Code: | ILY |
| Device Name: | ST-302 Infrarex |
| Manufacturer: | Skylark Device Company Limited |
4. Substantial Equivalence:
Detailed comparison data is included in Section 9 of "Substantial Equivalence Discussion" of this 510(k) submission.
A. Basic technological characteristics & Specifications, New device VS. Predicate device:
5
Pro Medical Supplies Inc. 1800 Byberry Rd. Unit 905, Huntingdon Valley, PA 19006, USA
| Parameters | New Device | Predicate Device | |
|---|---|---|---|
| 1 | 510(k) Number: | K140865 | K990233 |
| 2 | Marketing clearance date: | -- | Oct 27, 1999 |
| 3 | Proprietary Name: | Infrared Heating Device, Model | |
| PM-750 | ST-302 Infrarex | ||
| 4 | Manufacturer: | Shenzhen Yizekang Technologies Co., | |
| Ltd. | Skylark Device Company Limited | ||
| 5 | Indications for use: | The Infrared Heating Device, Model | |
| PM-750, temporarily increases local | |||
| blood circulation where applied, and | |||
| temporarily relieves minor muscle and | |||
| joint aches and pains. | The Infrarex temporarily increases local | ||
| blood circulation where applied, and | |||
| temporarily relieves minor muscle and | |||
| joint aches and pains. | |||
| 6 | Power source | 110V AC/60Hz | 110V AC/60Hz |
| 7 | Maximum output power | 7.5W | 7.5W |
| 8 | Power switch function | High/Off/Low | High/Off/Low |
| 9 | Type of heat source and number | 1 tungsten infrared bulb | 1 tungsten infrared bulb |
| 10 | Design Principle | FIR (far-infrared) therapy | FIR (far-infrared) therapy |
| 11 | Wavelength | 7 000 nanometers | 7 000 nanometers |
| 12 | Therapeutic temperature range | 40-45 °C | 40-45 °C |
| 13 | Approximate maximum skin | ||
| temperature | Low Level: 40.5°C | ||
| High Level: 44.5°C | Low Level: 40.5°C | ||
| High Level: 44.5°C | |||
| 14 | Time to reach therapeutic | ||
| temperature range | Low Level: 5~10 minutes | ||
| High Level: 3~5 minutes | Low Level: 5~10 minutes | ||
| High Level: 3~5 minutes | |||
| 15 | Recommended treatment time | Used for 15-20 minutes on target area | Used for 15-20 minutes on target area |
| 16 | Weight | 200g | 200g |
| 17 | Treatment area | 18cm² | 18cm² |
| 18 | Performance standards | ISO 10993-1, ISO 10993-5, ISO | |
| 10993-10, AAMI ANSI ES60601-1, | |||
| IEC 60601-1-2 | ISO 10993-1, ISO 10993-5, ISO | ||
| 10993-10, IEC 60601-1, IEC 60601-1-2 |
B. Substantial Equivalence Discussion
| Similarities between New device | The new device and the predicate device are produced by different |
|---|---|
| and Predicate Device: | manufacturers. |
| Differences between New device | Same intended use, design, materials, technical parameters, therapeutic |
| and Predicate Device: | parameters, and performance standards. |
| Conclusion: The two devices have exactly same intended use, design, materials, technical parameters, |
therapeutic parameters and performance standards.
The new device is as safe and effective as the predicate device.
5. Safety and Effectiveness of the device
Testing of Infrared Heating Device, Model PM-750, includes electrical safety testing and performance testing.
The device is manufactured to comply with the following international standards:
AAMI / ANSI ES60601-1:2005/(R) 2012 And A1:2012, C1:2009/(R)2012 And A2:2010/(R)2012 (Consolidated Text) Medical Electrical Equipment - Part 1: General Requirements For Basic Safety And Essential Performance.
IEC 60601-1-2:2007, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests The housing material and the material of the light filter of PM-750, ABS, was tested and found to meet the biocompatibility standards of:
6
-
ISO 10993-1:2009, Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
-
ISO 10993-5:2009, Biological evaluation of medical devices - Part 5: Tests for In Vitro cytotoxicity, and * ISO 10993-10:2010, Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity
In addition, two devices were tested for heat output, with the infrared light filter contacting the skin. Temperatures were recorded every 1 minute, up to 30 minutes, using a digital temperature sensor, through 6 participants on different body part. The test results concluded that the Infrared Heating Device, Model PM-750 was able to maintain temperature above 40℃ (the desired effective temperature) at least 10~15 minutes of the 30 minutes cycle time. The tests also showed that the temperature at the sensor (skin) never exceeded a temperature of 45℃. Both devices used for this test tracked each near 100%.
The conclusion drawn from the testing is that the device is substantially equivalent to the predicate devices.